Anti-virulence programs for wound infection

About Neem Biotech

Neem Biotech is a Cardiff-based, private biotech firm that has evolved from a natural products contract research organization into a drug discovery company with a core focus on antimicrobial resistance. Its strategy centers on a proprietary anti-virulence platform targeting bacterial-host interactions, which it uses to generate novel small molecule programs before spinning them out into dedicated subsidiaries for further development. The company's expertise spans chemistry, biology, and handling resistant pathogens in its specialized labs, positioning it to address significant unmet needs in infection management, particularly in wound healing. While currently pre-revenue and in the pre-clinical stage, its model aims to de-risk early-stage innovation and create value through focused venture creation.

Therapeutic Areas